Literature DB >> 5783125

Calciphylaxis in man.

J K Rees, G A Coles.   

Abstract

A patient with renal failure developed widespread calcification in the thighs after the injection of iron-dextran (Imferon). This is considered as an example of calciphylaxis, a process in which calcium is laid down in parts of the body following the administration of a "challenger." Iron-dextran is a known challenger, and should be used with caution in uraemic subjects, who may be sensitized by high serum parathyroid hormone levels. Contributing factors may have been a high calcium/phosphate product, steroids, and the patient's immobility.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5783125      PMCID: PMC1983649          DOI: 10.1136/bmj.2.5658.670

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  3 in total

1.  PROTECTION BY VARIOUS ANABOLIC STEROIDS AGAINST DIHYDROTACHYSTEROL INDUCED CALCINOSIS AND CATABOLISM.

Authors:  H SELYE; B TUCHWEBER; M JACQMIN
Journal:  Acta Endocrinol (Copenh)       Date:  1965-08

2.  THE TREATMENT OF CHRONIC RENAL FAILURE BY A MODIFIED GIOVANNETTI DIET.

Authors:  A B SHAW; F J BAZZARD; E M BOOTH; S NILWARANGKUR; G M BERLYNE
Journal:  Q J Med       Date:  1965-04

3.  Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma.

Authors:  S A Berson; R S Yalow
Journal:  Science       Date:  1966-11-18       Impact factor: 47.728

  3 in total
  10 in total

Review 1.  Calciphylaxis: diagnosis and clinical features.

Authors:  Matsuhiko Hayashi
Journal:  Clin Exp Nephrol       Date:  2013-02-21       Impact factor: 2.801

2.  Calcific Uremic Arteriolopathy Revisited.

Authors:  Anna Jovanovich; Michel Chonchol
Journal:  J Am Soc Nephrol       Date:  2016-05-25       Impact factor: 10.121

Review 3.  Calciphylaxis: risk factors, diagnosis, and treatment.

Authors:  Sagar U Nigwekar; Daniela Kroshinsky; Rosalynn M Nazarian; Jeremy Goverman; Rajeev Malhotra; Vicki Ann Jackson; Mihir M Kamdar; David J R Steele; Ravi I Thadhani
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

Review 4.  Calciphylaxis.

Authors:  Sagar U Nigwekar
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-07       Impact factor: 2.894

Review 5.  Calciphylaxis: a review.

Authors:  Cynthia M Magro; Richard Simman; Sarah Jackson
Journal:  J Am Col Certif Wound Spec       Date:  2011-03-27

Review 6.  Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate.

Authors:  Melvin R Hayden; David Goldsmith; James R Sowers; Ramesh Khanna
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

Review 7.  Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate.

Authors:  Melvin R Hayden; Suresh C Tyagi; Lisa Kolb; James R Sowers; Ramesh Khanna
Journal:  Cardiovasc Diabetol       Date:  2005-03-18       Impact factor: 9.951

8.  A Fatal Case of Penile Calciphylaxis.

Authors:  Carlos D'Assumpcao; Rupam Sharma; Addie Bugas; Arash Heidari; Rick A McPheeters; Shahab Hillyer
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

Review 9.  The Role of Iron in Calciphylaxis-A Current Review.

Authors:  Olivia Wickens; Sharmilee Rengarajan; Rajkumar Chinnadurai; Ian Ford; Iain C Macdougall; Philip A Kalra; Smeeta Sinha
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

10.  Calciphylaxis in peritoneal dialysis patients: a single center cohort study.

Authors:  Yanchen Zhang; Kristin M Corapi; Maria Luongo; Ravi Thadhani; Sagar U Nigwekar
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.